| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.26▲ | 7.11▲ | 7.04▲ | 7.25▲ | 7.90▼ |
| MA10 | 7.20▲ | 6.99▲ | 6.97▲ | 7.41▼ | 8.63▼ |
| MA20 | 7.12▲ | 7.00▲ | 7.08▲ | 7.67▼ | N/A |
| MA50 | 7.02▲ | 7.22▲ | 7.33▲ | 8.53▼ | N/A |
| MA100 | 7.15▲ | 7.44▼ | 7.36▼ | N/A | N/A |
| MA200 | 7.31▲ | 7.46▼ | 8.29▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.024▲ | 0.056▲ | 0.041▲ | -0.006▼ | N/A |
| RSI | 70.992▲ | 59.405▲ | 57.159▲ | 43.348▼ | 45.073▼ |
| STOCH | 90.052▲ | 86.097▲ | 65.288 | 40.491 | N/A |
| WILL %R | -1.149▲ | -0.769▲ | -0.769▲ | -53.378 | -83.302▼ |
| CCI | 154.287▲ | 183.038▲ | 213.759▲ | -66.580 | -61.581 |
|
Wednesday, August 13, 2025 01:15 PM
Presented preclinical data for JADE101 at the 62nd European Renal Association Congress, highlighting its potential as a best-in-class anti-APRIL monoclonal antibody for IgA nephropathy Phase 1 healthy ...
|
|
Wednesday, August 13, 2025 09:02 AM
Detailed price information for Jade Biosciences Inc (JBIO-Q) from The Globe and Mail including charting and trades.
|
|
Tuesday, July 15, 2025 05:00 PM
Equities researchers at Jefferies Financial Group started coverage on shares of Jade Biosciences (NASDAQ:JBIO – Get Free Report) in a report released on Monday, MarketBeat.com reports. The firm ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 6.79 | 7.38 | 6.67 | 7.36 | 185,222 |
| 14/08/25 | 7.76 | 7.76 | 6.71 | 6.77 | 77,453 |
| 13/08/25 | 7.25 | 7.402 | 7.1019 | 7.33 | 70,737 |
| 12/08/25 | 7.55 | 8.0036 | 7.30 | 7.39 | 75,677 |
| 11/08/25 | 7.41 | 7.72 | 7.205 | 7.40 | 69,162 |
| 08/08/25 | 7.39 | 7.5779 | 7.13 | 7.49 | 76,553 |
| 07/08/25 | 7.74 | 8.0011 | 7.22 | 7.32 | 114,710 |
| 06/08/25 | 7.92 | 8.13 | 7.78 | 7.83 | 97,929 |
| 05/08/25 | 7.26 | 8.15 | 7.18 | 7.94 | 122,524 |
| 04/08/25 | 6.93 | 7.37 | 6.73 | 7.29 | 99,707 |
|
|
||||
|
|
||||
|
|